close
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

GoodRx Holdings, Inc. - Class A Common Stock (NQ:GDRX)

2.180 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EST, Feb 12, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about GoodRx Holdings, Inc. - Class A Common Stock

< Previous 1 2
...
14 15 16 17 18 19 20 21 Next >
News headline image
12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗
Gainers Merrimack Pharmaceuticals (NASDAQ:MACK) shares rose 180.0% to $11.2 during Wednesday's pre-market session. The company's market cap stands at $150.1 million. As per the news, the Q3 earnings... 
Via Benzinga
News headline image
GoodRx Holdings, Inc. (GDRX) Q3 2022 Earnings Call Transcript ↗
GDRX earnings call for the period ending September 30, 2022. 
Via The Motley Fool
News headline image
GoodRx Reports Third Quarter 2022 Results
From GoodRx Holdings, Inc.
Via Business Wire
News headline image
Where GoodRx Holdings Stands With Analysts ↗
Over the past 3 months, 10 analysts have published their opinion on GoodRx Holdings (NASDAQ:GDRX) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a... 
Via Benzinga
News headline image
10 Analysts Have This to Say About GoodRx Holdings ↗
Within the last quarter, GoodRx Holdings (NASDAQ:GDRX) has observed the following analyst ratings: 
Via Benzinga
News headline image
Expert Ratings for GoodRx Holdings ↗
GoodRx Holdings (NASDAQ:GDRX) has observed the following analyst ratings within the last quarter: 
Via Benzinga
News headline image
What 13 Analyst Ratings Have To Say About GoodRx Holdings ↗
  GoodRx Holdings (NASDAQ:GDRX) has observed the following analyst ratings within the last quarter: 
Via Benzinga
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For November 4, 2022 ↗
Upgrades 
Via Benzinga
News headline image
New Report from GoodRx Shows Positive Impact of Giving Pharmacists the Power to Prescribe
From GoodRx
Via Business Wire
News headline image
GoodRx to Present at Upcoming Investor Conferences
From GoodRx Holdings, Inc.
Via Business Wire
News headline image
Should You Buy the Nasdaq's 4 Worst-Performing Stocks of 2022? ↗
These four tech stocks are down nearly 90%. 
Via The Motley Fool
News headline image
Before Pushing Others At Work, Take A Look In The Mirror ↗
Leaders often see their job as driving greatness from others. But the first step is developing your own leadership style. 
Via Investor's Business Daily
News headline image
GoodRx Announces Provider Mode, An Innovative Experience Built Specifically for Healthcare Providers
From GoodRx
Via Business Wire
News headline image
GoodRx and Biogen Collaborate to Help Enhance Enrollment Experience for Providers Who Have Chosen to Start Multiple Sclerosis Patients on VUMERITY®
From GoodRx
Via Business Wire
News headline image
GoodRx Announces Date for Third Quarter 2022 Earnings Release and Conference Call
From GoodRx Holdings Inc.
Via Business Wire
News headline image
Alphabet To $134? Plus This Analyst Slashes Price Target On McDonald's ↗
Credit Suisse cut the price target on Alphabet Inc. (NASDAQ: GOOGL) from $140 to $134. Credit Suisse analyst Stephen Ju maintained an Outperform rating on the stock. Alphabet shares fell 1.2% to $96.69... 
Via Benzinga
News headline image
Where GoodRx Holdings Stands With Analysts ↗
Over the past 3 months, 11 analysts have published their opinion on GoodRx Holdings (NASDAQ:GDRX) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a... 
Via Benzinga
News headline image
GoodRx Offers Free Telehealth Appointments to Florida Residents Affected by Hurricane Ian
From GoodRx
Via Business Wire
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For September 16, 2022 ↗
  
Via Benzinga
News headline image
What 14 Analyst Ratings Have To Say About GoodRx Holdings ↗
Over the past 3 months, 14 analysts have published their opinion on GoodRx Holdings (NASDAQ:GDRX) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a... 
Via Benzinga
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For September 7, 2022 ↗
Upgrades 
Via Benzinga
News headline image
GoodRx to Present at the Goldman Sachs Communacopia + Technology Conference
From GoodRx Holdings, Inc.
Via Business Wire
News headline image
Looking Into GoodRx Holdings's Return On Capital Employed ↗
GoodRx Holdings (NASDAQ:GDRX) brought in sales totaling $191.80 million during Q2 according to data provided by Benzinga Pro. However, earnings decreased 111.51%, resulting in a loss of $1.42 million. 
Via Benzinga
News headline image
This Healthcare Stock Dipped Over 30%; Here Are 83 Biggest Movers From Yesterday ↗
Gainers 
Via Benzinga
News headline image
GoodRx Holdings, Inc. (NASDAQ: GDRX) Investor Alert: Investigation over Potential Wrongdoing ↗
San Diego, CA -- (SBWIRE) -- 08/15/2022 -- An investigation was announced over potential breaches of fiduciary duties by certain directors at GoodRx Holdings, Inc. 
Via SBWire
News headline image
The Most Expensive Drug From Novartis Associated With Two Deaths: Report ↗
Two children with spinal muscular atrophy have died after receiving Novartis AG's (NYSE: NVS) Zolgensma, a one-time gene therapy, spotlighting its risks and questioning the safety of genetic medicines... 
Via Benzinga
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For August 12, 2022 ↗
  
Via Benzinga
News headline image
WeTrade, Roblox And Some Other Big Stocks Moving Lower On Wednesday ↗
  OptimizeRx Corporation (NASDAQ: OPRX) shares fell 26.7% to $16.32 after the company reported worse-than-expected Q2 EPS and sales results and issued FY22 sales guidance below estimates. 
Via Benzinga
News headline image
Why Verona Pharma Is Trading Higher By Around 84%, Here Are 85 Stocks Moving In Tuesday's Mid-Day Session ↗
Gainers Verona Pharma plc (NASDAQ: VRNA) shares jumped 83.6% to $12.70 after the company announced ensifentrine met its primary endpoint and secondary endpoints in the Phase 3 ENHANCE-2 trial for COPD.... 
Via Benzinga
News headline image
Qualys, ShockWave Medical, News Corporation And Some Other Big Stocks Moving Higher On Tuesday ↗
  Verona Pharma plc (NASDAQ: VRNA) shares jumped 83.6% to $12.70 after the company announced ensifentrine met its primary endpoint and secondary endpoints in the Phase 3 ENHANCE-2 trial for COPD. The... 
Via Benzinga
< Previous 1 2
...
14 15 16 17 18 19 20 21 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Starting at $3.75/week.

Subscribe Today